Investigating new treatments for infectious diseases.
Early Phase Clinical Trial Unit
['FUNDING_OTHER'] · DUKE UNIVERSITY · NIH-10788090
This study is looking for people to help test new treatments for infectious diseases, giving you a chance to try out the latest therapies while helping advance medical knowledge.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | DUKE UNIVERSITY (nih funded) |
| Locations | 1 site (DURHAM, UNITED STATES) |
| Trial ID | NIH-10788090 on ClinicalTrials.gov |
What this research studies
This research focuses on early phase clinical trials that explore new agents aimed at treating and preventing infectious diseases. Patients may have the opportunity to participate in trials that test innovative therapies and interventions designed to combat various infectious disorders. The approach involves rigorous testing and evaluation of these new treatments to determine their safety and effectiveness. By participating, patients can contribute to the advancement of medical knowledge and potentially benefit from cutting-edge therapies.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals diagnosed with infectious diseases who are seeking new treatment options.
Not a fit: Patients with non-infectious diseases or those who do not meet the specific criteria for the trials may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new and effective treatments for infectious diseases, improving patient outcomes.
How similar studies have performed: Previous research in early phase clinical trials for infectious diseases has shown promise, indicating that this approach can lead to significant advancements in treatment.
Where this research is happening
DURHAM, UNITED STATES
- DUKE UNIVERSITY — DURHAM, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GUPTILL, JEFFREY — DUKE UNIVERSITY
- Study coordinator: GUPTILL, JEFFREY
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Communicable Diseases, Infectious Disease Pathway, Infectious Diseases, Infectious Disorder, National Institute of Allergy and Infectious Disease